The
design of advanced nanobiomaterials to improve analytical accuracy
and therapeutic efficacy has become an important prerequisite for
the development of innovative nanomedicines. Recently, phospholipid
nanobiomaterials including 2-methacryloyloxyethyl phosphorylcholine
(MPC) have attracted great attention with remarkable characteristics
such as resistance to nonspecific protein adsorption and cell adhesion
for various biomedical applications. Despite many recent reports,
there is a lack of comprehensive review on the phospholipid nanobiomaterials
from synthesis to diagnostic and therapeutic applications. Here, we
review the synthesis and characterization of phospholipid nanobiomaterials
focusing on MPC polymers and highlight their attractive potentials
for applications in micro/nanofabricated fluidic devices, biosensors,
lab-on-a-chip, drug delivery systems (DDSs), COVID-19 potential usages
for early diagnosis and even treatment, and artificial extracellular
matrix scaffolds for cellular engineering.